Ownership history in Commodore Capital LP · 16 quarters on record
This page tracks every 13F SEC filing in which Commodore Capital LP reported a position in VISTAGEN THERAPEUTICS INC (VTGN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | UNCHANGED | 1,575,000 | — | 0% | 0.27% | $5.6M | $3.55 |
| 2025 Q2 | UNCHANGED | 1,575,000 | — | 0% | 0.22% | $3.1M | $2.00 |
| 2025 Q1 | UNCHANGED | 1,575,000 | — | 0% | 0.29% | $3.9M | $2.50 |
| 2024 Q4 | UNCHANGED | 1,575,000 | — | 0% | 0.34% | $4.6M | $2.95 |
| 2024 Q3 | UNCHANGED | 1,575,000 | — | 0% | 0.30% | $4.7M | $3.01 |
| 2024 Q2 | UNCHANGED | 1,575,000 | — | 0% | 0.37% | $5.5M | $3.48 |
| 2024 Q1 | UNCHANGED | 1,575,000 | — | 0% | 0.56% | $8.3M | $5.28 |
| 2023 Q4 | UNCHANGED | 1,575,000 | — | 0% | 0.70% | $8.1M | $5.14 |
| 2023 Q3 | REDUCED | 1,575,000 | -11,474,079 | -87.9% | 0.96% | $8.3M | $5.24 |
| 2022 Q2 | ADDED | 13,049,079 | +2,951,850 | +29.2% | 2.43% | $11.5M | $26.40 |
As of 2025 Q4 — sorted by position size